Mequitazine for treating or preventing pathologies involving histamine H4 receptors
    2.
    发明公开
    Mequitazine for treating or preventing pathologies involving histamine H4 receptors 审中-公开
    美喹他嗪,涉及组胺H4受体治疗或预防疾病

    公开(公告)号:EP2255811A1

    公开(公告)日:2010-12-01

    申请号:EP10177151.7

    申请日:2008-12-04

    摘要: The present application relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10 H -phenothiazine, 10-[(3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10 H -phenothiazine or 10-[(3R,3S)-1-azabicycio[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or a pharmaceutically acceptable salt thereof, to prepare a drug to prevent or treat pathologies involving histamine H4 receptor, chosen among atopic dermatitis and pruritus.

    摘要翻译: 本申请涉及使用的10 - [(3R)-1-氮杂双环[2.2.2]辛-3-基 - 甲基] -10ħ - 吩噻嗪,10 - [(3S)-1-氮杂双环[2.2.2] 辛-3-基甲基] -10ħ - 吩噻嗪或10 - [(3R,3S)-1-氮杂双环[2.2.2]辛-3-基甲基] -10H-吩噻嗪或其药学上可接受的盐,以制备药物 预防或治疗疾病涉及组胺H4受体,特应性皮炎和皮肤瘙痒中选择。